(lp0
S'Update - Ampio Pharmaceuticals Provides Corporate Update PR Newswire  - 10 hours ago ENGLEWOOD, Colo., March 22, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. , a leader in the development of Ampion, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, today announced&nbsp;...'
p1
aS'Ampio Pharmaceuticals Provides Corporate Update PR Newswire  - Mar 20, 2017 ENGLEWOOD, Colo., March 20, 2017 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. , a leader in the development of Ampion, a low molecular weight fraction of human serum albumin with anti-inflammatory properties, announced an&nbsp;...'
p2
aS'Ampio Pharmaceuticals - Running On Fumes Seeking Alpha - Feb 1, 2017 My interest in Ampio Pharmaceuticals Inc.,  was established several days ago during the Optometric Leaders Forum in Montreal, Canada.Ampio Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 01 - Equities.com'
p3
aS'Ampio Pharmaceuticals Inc.  Plunges 5.11% on March 21 Equities.com - Mar 21, 2017 Ampio Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 5.11%, or a loss of $-0.0437 per share, to close at $0.81.'
p4
aS'0.82 MarketWatch - Apr 18, 2011 Ampio Pharmaceuticals Inc. Watchlist CreateAMPEAlert. Open. Last Updated: Mar 21, 2017 2:58 p.m. Real time quote. $ 0.82. -0.04 -4.13%. Previous Close. $0.86. Created with Highstock 2.1.8 10am 1pm $0.80 $0.82 $0.84 $0.86 $0.88. Advanced Charting.'
p5
aS"Breaking Down: Ampio Pharmaceuticals Inc  Stock Drop Below Support ... CML News - 17 hours ago Ampio Pharmaceuticals Inc has a one bull  technical rating because it's trading below the 10 day, 50 day and 200 day simple moving averages while the 10-day moving average is below the 50-day moving average and the 50-day moving&nbsp;..."
p6
aS'Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA ... PR Newswire  - Oct 14, 2015 ENGLEWOOD, Colo., Oct. 14, 2015 /PRNewswire/ - Ampio Pharmaceuticals, Inc.  today announced that Ampio met with the Division of the Transplant and Ophthalmology Products of the FDA to discuss the results of the OptimEyes&nbsp;...Ampio Pharma updates on path to FDA approval for DME drug Optina - The Pharma Letter '
p7
aS'Ampio Pharmaceuticals Inc. AMPE  Wall Street Journal - May 20, 2011 Ampio Pharmaceuticals Inc. AMPE . search. View All companies. AT CLOSE 4:02 PM EST 03/10/17. $0.80 USD; 0.00 -0.12%.'
p8
aS'Investor Focus on Shares of Ampio Pharmaceuticals Inc  Midway Monitor - 8 hours ago Investors are paying close attention to shares of Ampio Pharmaceuticals Inc . A popular tool among technical stock analysts is the moving average.Watching the Numbers for Parex Resources Inc  - Providence Standard'
p9
aS'Ampio Pharmaceuticals  Stock Tanks Today after Treatment Fails To Reach ... TheStreet.com - Apr 20, 2015 NEW YORK  -- Ampio Pharmaceuticals  shares are down 65.76% to $2.71 in trading on Monday after the biopharmaceutical company announced that the multiple injection STRIDE study for pain reliever Ampion did not reach its primary&nbsp;...AMPIO Announces Ampion STRIDE Study Results - PR Newswire '
p10
a.